Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Q/C Technologies, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q1 2024
- Shares held
- 62.0K
- −855.8K (−93.2%) vs. Q1 2024
- Total value
- $114.6K
- −$1.26M (−91.7%) vs. Q1 2024
- New holders
- 6
- 2 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 12 | $69.8K |
| Q2 2025 | 33 | $65.3K |
| Q1 2025 | 24 | $69.0K |
| Q4 2024 | 25 | $145.8K |
| Q3 2024 | 20 | $60.3K |
| Q2 2024 | 23 | $114.6K |
| Q1 2024 | 20 | $1.38M |
| Q4 2023 | 50 | $1.64M |
| Q3 2023 | 51 | $2.52M |
| Q2 2023 | 48 | $6.51M |
| Q1 2023 | 50 | $6.98M |
| Q4 2022 | 43 | $4.49M |
| Q3 2022 | 43 | $9.94M |
| Q2 2022 | 39 | $10.3M |
| Q1 2022 | 35 | $22.4M |
| Q4 2021 | 41 | $27.1M |
| Q3 2021 | 28 | $41.8M |
| Q2 2021 | 23 | $30.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 15,822 | $29.1K | 0.00% | +13,800+682.5% | Added |
| Geode Capital Management, LLC | 14,410 | $26.5K | 0.00% | +14,410 | New |
| Vanguard Group Inc | 13,999 | $25.8K | 0.00% | −16,658−54.3% | Reduced |
| Virtu Financial LLC | 11,688 | $22.0K | 0.00% | +11,688 | New |
| BlackRock Inc. | 3,803 | $7.00K | 0.00% | −2,999−44.1% | Reduced |
| Parallel Advisors, LLC | 838 | $1.54K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 387 | $712 | 0.00% | −72−15.7% | Reduced |
| Advisor Group Holdings, Inc. | 266 | $487 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 193 | $355 | 0.00% | −31−13.8% | Reduced |
| Wells Fargo & Company | 167 | $307 | 0.00% | −10−5.6% | Reduced |
| Sandy Spring Bank | 116 | $214 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 90 | $166 | 0.00% | 00.0% | Unchanged |
| Redwood Wealth Management Group, LLC | 50 | $92 | 0.00% | +50 | New |
| Tower Research Capital LLC (TRC) | 39 | $72 | 0.00% | +39 | New |
| Newbridge Financial Services Group, Inc. | 34 | $63 | 0.00% | 00.0% | Unchanged |
| Arvest Investments, Inc. | 34 | $62 | 0.00% | 00.0% | Unchanged |
| Mather Group, LLC. | 17 | $41 | 0.00% | +17 | New |
| St. Johns Investment Management Company, LLC | 18 | $33 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 16 | $30 | 0.00% | +15+1,500.0% | Added |
| Qube Research & Technologies Ltd | 3 | $6 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 1 | $2 | 0.00% | +1 | New |
| Royal Bank of Canada | 40 | $0 | 0.00% | −39−49.4% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −875,933−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |